From Ars Technica
Millions of Americans are not taking their GLP-1 drugs as prescribed
Cost and access barriers are pushing people to modified use and unapproved versions.
TechTrends NowFollow the next shiftTechnology · Culture · ChangeTechTrends NowFollow the next shiftTechnology · Culture · ChangeFrom Ars Technica
Cost and access barriers are pushing people to modified use and unapproved versions.